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Danielle Dean 
Barbara Mellers 
Medication nonadherence is a significant global problem that results in higher mortality 
and healthcare costs. There has been a recent increase in digital health companies that aim to 
facilitate behavior change to encourage and promote healthy behaviors, with medication adherence 
being a key focus for many. This paper identifies several behavioral drivers associated with 
medication nonadherence and identifies key components in program design where behavioral 
science should be considered in order to make a strong lasting impact. This paper also presents a 
framework for incorporating behavioral science concepts in health program design and outlines a 
methodology for testing and validating results. I also explore a case study identifying a digital 
health program that has successfully utilized behavioral science to improve program design and 
increase the desired behavior. The purpose of this paper is to provide a low-cost framework for 
incorporating behavioral science into medication adherence program design to increase efficacy 
in behavior change and ultimately improve individual quality of life and lower overall societal 
healthcare costs. 
 













 Medication nonadherence is a significant problem in the United States and is associated 
with 125,000 deaths, 10% of hospitalizations and $100 billion in avoidable health care services 
annually (Kini & Ho, 2018). Patients with chronic illnesses have the lowest adherence rate where 
30% to 50% of medications are not taken as prescribed (Kini & Ho, 2018). Chronic diseases not 
only account for the lowest adherence rates, but the economic burden due to chronic diseases 
such as heart disease, obesity and cancer has reached $3.8 trillion in direct and indirect costs 
(Reed, 2019). Cost, forgetfulness, and ease of fulfillment have been shown to be major barriers 
that prevent patients from adhering to their prescribed medication (Gebremedhin & Werner, 
2017). Government officials and healthcare payers such as Medicaid, Medicare, and private 
insurance companies, are interested in solving this problem not only to lower mortality rates and 
increase quality of life, but also to reduce the significant economic burden of healthcare costs. 
National health spending reached $3.6 trillion in 2018 and is expected to grow at an average rate 
of 5.5 percent hitting $6 trillion by 2027 (Figure 1) (Centers for Medicare & Medicaid Services, 
2019). Increasing medication adherence will improve the quality of patient health and indirectly 
lower costs by reducing avoidable hospitalizations and preventing disease progression.  
A specific population of interest are patients with chronic diseases because they have the 
lowest adherence rate averaging 50% in developed countries worldwide and even lower rates in 
developing countries (World Health Organization, 2003). Low-income individuals are 
disproportionately affected by chronic diseases and there are competing needs from those 
suffering from chronic poverty with needs of treating chronic health conditions (World Health 
Organization, 2003). Medication nonadherence is increased for chronic disease states, such as 
hypertension, where missing a day of medication does not result in immediate negative 
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consequences. Nonadherence is greatest when patients are asymptomatic to missed doses and 
when medication has to be taken over a long period of time (Jimmy & Jose, 2011). Therefore, 
chronic disease states present a large market opportunity.  
Interventions and health programs tried thus far have seen mixed results and generally 
fall under six categories: patient education, medication regiment management via reduction of 
pills, clinical pharmacist consultation for disease co-management, cognitive behavioral therapies, 
medication-taking reminders and incentives (Kini & Ho, 2018). The most significant limitations 
seen in adherence solutions are cost-effectiveness and patient engagement (Gebremedhin & 
Werner, 2017). The interventions that have been most successful are logistically complicated, 
labor intensive and expensive; therefore, a cost-effective behavioral science design is needed to 
overcome these barriers. There is a large market opportunity to develop a low-cost health 
program that increases patient engagement and medication adherence (Figure 2). It is important 
to note that adherence is simultaneously influenced by multiple factors including social, 
economic, health care team, characteristics of the disease, disease therapies and patient-related 
factors (World Health Organization, 2003).   
Medication Adherence with Digital Health 
With the healthcare industry shifting to value-based and outcome-based payment models, 
patient outcomes are increasingly important for securing favorable medication reimbursement. 
Pharmaceutical and biotech companies are therefore becoming more incentivized to focus on 
patient outcomes to increase revenue (Taylor et al., 2017). To adapt to the evolving market, 
Pharma is investing and partnering with digital health companies that are developing products to 
improve patient adherence rates and focusing on patient-centric strategies for customer-centered 
commercialization (Taylor et al., 2017). Improving engagement with customers through 
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technology is a key component in patient-centric models, and partnerships with digital health 
companies help facilitate that shift. 
 The Food and Drug Administration defines digital health as a broad scope of categories 
including mobile health, health information technology, wearable devices, telehealth, 
telemedicine, and personalized medicine (FDA, 2019). Digital health companies have found an 
opportunity to use technology to develop effective programs to combat barriers and improve 
medication adherence. Digital programs aim to improve medication adherence through digital 
medication tracking and reminders, educational and motivational tools, gamification and 
incorporating behavioral economics principles into the design to increase engagement and 
improve results. An analysis from Express Scripts revealed that value-based programs keep costs 
down and improve patient outcomes; increased adherence for diabetics was facilitated through 
the Mango Health digital application that increased consumer engagement with positive health 
behaviors (Renfrow, 2019). 
 Investment in digital health has seen significant growth with $8.1 billion spent on funding 
in 2018 compared to $5.7 billion in 2017 (Figure 3) (Day & Zweig, 2018). Biotech and 
pharmaceutical companies have been increasing investment in digital health since 2014, with 25 
transactions in 2018 (Figure 4) (Day & Zweig, 2019). Pharmaceutical companies are beginning 
to invest more in partnerships with digital health companies in an attempt to address current 
issues with medication adherence. Successful digital health companies will develop programs 
that have high patient activation, while minimizing patient responsibility. As the technology 
becomes more passive and integrated, patient activation is simplified for the end-user, the 
efficacy of the adherence product increases, and patient adherence to therapy dramatically 
increases (Gebremedhin & Werner, 2017). Companies that understand the challenges of the 
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afflicted patients and can design products to integrate seamlessly into the daily lives of the end-
user will be the most successful in achieving high adoption and adherence rates. 
Incorporating Behavioral Science 
Behavioral economics explains how people are predictably irrational, and it can also 
reveal how to utilize decision errors in order to help people. Using behavioral economics to 
create an impactful intervention for behavior change is a less expensive and more efficient 
method than investing resources in the development of new treatments. With increased 
investment in digital health, and medication adherence as a key market opportunity, 
incorporating behavioral science in program design can have a significant impact on behavior 
change. This paper identifies several behavioral drivers that contribute to medication 
nonadherence and identifies key behavioral science concepts that should be considered in the 
design of digital health programs aimed at changing adherence behavior. I present an overall 
framework and methodology for incorporating behavioral science in program design and the 
importance of testing and analyzing data before scaling. I then address key behavior-change 
challenges in the field and conclude with a case study on a medication adherence program 
partnership between HealthPrize and Boehringer Ingelheim.  
 
Behavioral Drivers 
A behaviorally inspired program needs to consider behavioral drivers to design a more 
effective intervention. This will subsequently lower the incidence of nonadherence in a more 
cost-effective manner with a greater impact. Several underlying decision errors contribute to 
challenges individuals face in forming healthy behavior change. 
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A significant behavioral driver attributed to medication nonadherence is present bias. 
Present bias is the tendency for people to discount larger future rewards and prefer smaller 
immediate rewards. Present bias causes patients to discount future payoffs which makes it hard 
to motivate change when rewards are more distant, especially when the change requires constant 
work. Because of hyperbolic discounting, adhering to medication in the future may be seen as 
having more value than adhering today, which leads to an endless cycle of procrastination. 
Medication nonadherence is increased for chronic disease states, such as cardiovascular disease, 
where missing a day of medication does not result in any immediate negative consequences. If 
there are no painful symptoms that the medication addresses, then there is no immediate reward 
(pain alleviation) associated with taking the medication. Nonadherence is greatest when patients 
are asymptomatic to missed doses and when medication must be taken over a long period of time 
(Jimmy & Jose, 2011). The immediacy and saliency of feedback is essential to encourage a 
behavior, which is lacking for this type of medication and disease state. 
Time inconsistency with hot and cold states can also cause patients to make choices that 
are not always in their best interest. Emotions and environmental context impacts decision-
making; facing temptations (a hot state) versus thinking about future wellbeing away from 
temptation (a cold state) results in very different decisions. While in a hot state, patients do not 
always consider long-term consequences, which is especially true for patients taking medication 
that doesn’t provide immediate feedback such as symptom relief. The peanuts effect is the 
tendency for people to be less risk averse with decreasing monetary amounts, meaning that 
people are willing to take more risks when “playing for peanuts.” This is a challenge for 
behavior change programs, because small gains or losses tend to not be very motivating. This 
effect is seen when people miss a dose of their medication, because it is easy for them to 
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rationalize that one missed dose would not affect the overall efficacy. Strong incentives for 
motivating medication adherence are needed to counteract these powerful biases and decision 
errors. 
 
Program Design Features Incorporating Behavioral Drivers 
Behavioral science should be considered in many aspects of program design. For 
example, simple changes in the wording of messages can have a large impact on behavior. 
Several program design elements are discussed in this section that require evaluation from a 
behavioral science perspective in order to make the largest possible impact on behavior change. 
The main program design elements discussed in this section include incentives, defaults, 
reminders, messaging and goal setting, where decision heuristics and associated biases are 
further discussed within each topic.  
Incentives 
Financial incentives work by changing the ratio of benefits to cost, and as prices of a 
service change, utilization will change. While financial incentives have the potential to improve 
adherence, the feasibility and scalability have been barriers due to insufficient resources. A 
behaviorally inspired approach can provide a cost-effective alternative that is feasible and 
scalable across the United States. A behavioral approach in the design of financial incentives is 
important, because how they are situated and framed can have a large impact on their success. 
This is particularly crucial for chronic disease patients, especially those that do not receive a 
direct positive or negative health effect immediately after adherence or nonadherence. Present 
bias, prospect theory, framing effects, mental accounting, and non-cash rewards should be 
considered when designing incentives for medication adherence programs. 




 Due to present biased preferences, external rewards are essential to provide motivation to 
supplement insufficient intrinsic motivation for behaviors that do not have immediate benefits, 
such as taking medication for chronic illnesses. Hyperbolic discounting causes people to over-
weight immediate costs and benefits relative to those occurring in the future. Therefore, effective 
financial incentives should be as close in time as possible to the desired action. 
How incentives are situated and framed can have a significant effect of their success; 
providing the incentive at the time when risks of negative outcomes are high are more likely to 
increase the desired behavior change (Thirumurthy et al., 2019). Present-biased preferences can 
be exploited to help individuals by altering immediate costs and benefits by making healthy 
behaviors more convenient and less immediately costly (Loewenstein et al. 2007). Offering small 
incentives in the short term to help people achieve smoking cessation has shown to be much 
more successful than relying on the greater delayed incentives associated with cessation (Volpp 
et al. 2009). Extending from the success with smoking cessation, these financial incentives could 
be used in other contexts where present bias is a behavioral driver such as medication adherence. 
Prospect Theory, Loss Aversion and Framing Effects. 
 Loss aversion is the tendency to prefer avoiding losses as opposed to acquiring equivalent 
gains, because “losses loom larger than gains” (Kahneman & Tversky, 1979). The disutility 
associated with losing money is much greater than the utility of receiving that exact same 
amount of money. This is represented in the value function of prospect theory, where the slope is 
much steeper in the loss domain. Loss aversion also explains the endowment effect where people 
overvalue items they possess. This has been demonstrated in many experiments, most famously 
in an experiment at Cornell where students that were endowed with a mug, also priced the mug 
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approximately twice as high as the students that were willing to pay to acquire it (Kahneman et 
al. 1990).  
An important insight from prospect theory is that people are reference dependent in how 
they perceive outcomes, so framing the same information in the loss or gain domain has a 
different effect. Designing program incentives in the loss domain so that the financial reward is 
endowed at the beginning but with the potential to lose it, induces loss aversion which can be 
much more effective than a traditional gain domain incentive. This was shown to be successful in 
an experiment that utilized loss aversion with financial incentives to improve teacher 
performance (Fryer et al. 2012). In the treatment group, teachers were given a bonus in advance 
and had to give the money back if their students did not perform sufficiently. The control group 
implemented the bonus in the standard gain domain fashion. The results from this study yielded a 
large difference in teacher quality with a significant increase in test scores for the loss domain 
group. Another design consideration is to allow participants to have the ability to win back 
deductions as well as win additional rewards by completing extra goals. This component is key 
to keeping people engaged and motivated by the potential to win more rewards rather than only 
being motivated to avoid losses. 
Mental Accounting. 
It is also important to consider other biases and heuristics that would make health 
programs more successful. Mental accounting is the tendency for people to organize their money 
in separate accounts associated with their intended use which violates the economic principle 
that money is fungible (Thaler, 1999). With mental accounting, making gains more salient will 
cause the intervention to be more effective. Many insurance companies and employers use 
premium health insurance discounts to motivate healthy behavior; however, this strategy may not 
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be as effective as offering people a separate bonus check rather than a discount because a bonus 
check is in a separate mental account than the healthcare account. Patel et al. (2016) found no 
significant effect for obese participants in a workplace wellness weight loss program who were 
offered a discounted premium incentive of $550 versus the control group. Adjusting premium 
prices or adding funds to a paycheck is not nearly as salient as giving participants a separate 
bonus check. For example, adding $100 becomes invisible when added to a paycheck, but if 
presented as a gift card or bonus check then it becomes much more salient and pleasurable as the 
person can then choose to assign the funds to whichever “mental account” they desire. Also, if 
rewards are too small, then they will not be very motivating. In delivering financial rewards it is 
more effective to bundle them and deliver monthly to create larger aggregate payments. 
Non-cash Incentives. 
  Incentives that motivate people to perform a particular behavior do not always have to be 
financial rewards. People actually tend to think more frequently about non-cash rewards than 
financial rewards while performing the incentivized task, which creates a stronger positive effect 
associated with non-cash incentives (Jeffrey & Adomdza, 2010). Jeffrey and Adomdza showed 
that people performed better when incentivized with merchandise or travel rewards compared to 
people incentivized with an equivalent cash reward. People exert more effort when rewards are 
highly salient. While cash incentives can be motivating with the benefit of allowing the 
individual to choose how to use it, the cash incentive can also be put towards paying bills, which 
is why merchandise or experience incentives can be ultimately more satisfying than cash. 
 




Status quo bias is the tendency for people to stick with their current default choice or 
routine even if a better alternative exists. This was famously demonstrated when consumers in 
Pennsylvania and New Jersey had the option to purchase lower cost automobile insurance for the 
limited right to sue or higher cost insurance for the full right to sue (Johnson et al., 1993). In 
Pennsylvania, the default was for the higher cost insurance and in New Jersey, the default was 
for the lower cost insurance; however, the consumer had the ability to choose either option. In 
Pennsylvania, 70% of drivers chose the default higher cost insurance, while in New Jersey 79% 
of drivers stuck with the default lower cost insurance. These results demonstrate the significant 
power the default option has over consumer decision-making. 
Motivating people to change from the status quo can be challenging. Change can require 
a lot of effort and if the alternatives aren’t powerful enough, people are more inclined to continue 
with their current behaviors. Anticipated regret also ties in with status quo bias, because a bad 
outcome from sticking with the default hurts less than a bad outcome from making a choice or an 
action. This anticipated regret can paralyze people from moving away from the status quo and 
from deciding on something other than the default option. It is important to capitalize on this 
tendency, by designing choice architecture to make the default option beneficial for the 
consumer. With medication adherence, designing the program to automatically reorder 
medication can reduce medication gap periods and alleviate consumers’ stress from having to 
remember to reorder each month. This feature can be designed as ‘opt out’ rather than ‘opt in’ so 
that people are automatically enrolled and can choose to opt out if desired; this is an example of 
liberal paternalism where it is designed to the people without restricting their choice. 
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Reminders and Messaging 
 Medication adherence reminders are another key design aspect in health program design. 
Many chronic disease patients require taking daily pills and sometimes more than once per day. 
This can be inconvenient and easy to forget, or there can also be other social factors at play that 
cause individuals to miss a dose. It is also important to note that reminders and messages can be 
effective at first but may also cause people to unsubscribe if messages come at an inconvenient 
time. One study found that reminder donation emails increased one-time donations by 66 
percent, but also increased unsubscribing from the mailing list by 76 percent (Gravert, 2019). 
While being reminded to take a medication is much different than being asked to donate, this 
study provides an important lesson that timing of messages can be crucial to their success; 
messages should be customizable to the individuals’ schedule and needs.  
Social Norms. 
Incorporating social norm theory by diagnosing and measuring collective behaviors will 
ensure that health programs work effectively. A big mistake people often make is assuming that 
informational campaigns will change behavior. This not only assumes people are rational, but 
also that the behavior is a custom and factual beliefs alone are driving the behavior. Therefore, 
presenting people with information on why medication adherence is good for their health is not 
enough to motivate change. 
Preferences are formed from a combination of beliefs and/or expectations. The types of 
beliefs and expectations include factual beliefs, personal normative beliefs, empirical 
expectations and normative expectations. Empirical expectations are beliefs about what the 
individual expects others do (Bicchieri, 2015). Normative expectations are second order beliefs 
about what personal normative beliefs one expects others to have (Bicchieri, 2015). While these 
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beliefs and expectations may exist, not all of them contribute to the motivation behind the 
behavior. 
The classification of preferences as conditional or unconditional is an important 
measurement step in diagnosing collective behaviors. Preferences involve individual or social 
beliefs and expectations that contribute to different reasons for participation in group behaviors. 
Conditional preferences depend on what one believes others do or what one believes others think 
they should do, while unconditional preferences are individual choices regardless of others’ 
actions or beliefs (Bicchieri, 2015). Classifying preferences as conditional or unconditional 
provides insight into the reasoning behind individual involvement in a collective behavior. 
Conditional preferences are necessary for social and descriptive norms, whereas unconditional 
preferences play a role in customs and moral norms. 
A descriptive norm is an interdependent behavior that is conditionally preferred based on 
the expectation that others engage in the behavior. A social norm is an interdependent rule of 
behavior that is conditionally preferred because others are engaging in the behavior and 
individuals expect that others think they should also engage in the behavior. Measurement is 
essential for correct diagnosis of collective patterns of behavior in order to design effective 
interventions to promote positive change. It is an iterative design process that requires multiple 
stages and testing.  
Norm creation and norm abandonment are two social norm strategies to change a 
behavior. This requires changing beliefs, a collective decision by the community to change, 
introduction of sanctions, creation of normative expectations and the creation of empirical 
expectations. For norm abandonment there must be the creation of new empirical expectations 
before normative expectations. Research has shown that second-order normative expectations are 
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more powerful predictors of behavior that personal normative beliefs (Jachimowicz, Hauser, 
O'Brien, Sherman, & Galinsky, 2018). Thus, creating a new social norm can be a very effective 
strategy to promote positive behavior change. 
A social norm intervention strategy can address multiple motivations because sometimes 
creating a new social norm gets rid of independent motivations such as customs, factual beliefs 
and personal normative beliefs. There are some specific individuals or groups of people that can 
be leveraged in order to promote positive social change. Centola claims that social norms can be 
changed by small minority groups when they reach a critical mass that crosses a tipping point 
(Centola, Becker, Brackbill, & Baronchelli, 2018). After this threshold is reached, behavior 
change occurs rapidly, accepting the minority groups’ point of view. 
Social comparison feedback is one strategy that could be used to increase medication 
adherence. Communicating to patients where they stand in comparison to their peers would be 
effective for those motivated by social expectations. It is important to only provide this feedback 
to patients at the lower end of the spectrum. If social comparison information is given to the 
people with the highest adherence rates, this may cause the reverse effect in their adherence. 
Social comparison feedback was looked at by Wesley Schultz and colleagues who tested 
normative messaging to promote household energy conservation (Schultz et al., 2007). A 
descriptive normative message revealing energy usage of neighbors produced the desirable 
energy savings behavior change in some but the opposite effect in others depending on their 
baseline usage. Households that were high energy users reduced, but households that were low 
energy users ended up consuming more energy as a result of the messaging. Providing 
descriptive normative information is intended to decrease undesirable behavior of those people 
engaging in the behavior at a high rate, but it can also increase the undesirable behavior in those 
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individuals who were engaging in that same behavior at a low rate (Schultz et al., 2007). 
However, Schultz’ experiment showed that adding an injunctive message conveying social 
approval or disapproval eliminated the negative boomerang effect; the low rate energy 
consumers continued at the same rate with the addition of the injunctive message (Schultz et al., 
2007). When providing social comparison information about medication adherence rates, 
interventions should either only provide the information to bottom half or they should add 
injunctive messaging to ensure a reverse effect does not occur for high adherers.  
It is also important to determine the reference network important for this behavior, 
especially if the behavior is interdependent. If the relevant reference network is uncertain, more 
vague terms can be used in messages such as “in your community” to allow participants to fill in 
the people that matter for this behavior. Another factor to consider is whether the individual 
should receive adherence reminders or instead if sending the reminder to a caretaker, family 
member or friend would be more effective. 
In general, if an individual observes many other people doing (empirical expectations) or 
thinking (normative expectations) something, their actions or thoughts convey information about 
what may be best for the individual to think or do. Therefore, people’s health behaviors may be 
influenced by others and diagnosing and measuring behavior is crucial to creating effective 
messaging that will motivate behavior change. 
Anticipated Regret. 
Anticipated regret can be a powerful motivator by making rewards other people are 
receiving more salient to each individual. People do not want to feel like they missed an easy 
opportunity to earn rewards. Unlike the feeling of disappointment which is experienced when a 
different outcome would have produced a happier result and is out of the control of the 
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individual, regret is experienced when a different choice made by the individual would have 
produced a better result. By making people aware of what they could have easily won, “the 
counterfactual looms incredibly and painfully large” (Ariely, 2012). Anticipated regret is a 
powerful concept that can be incorporated into health programs through messaging to increase 
effectiveness without the use of additional money. 
Goal Setting 
  Goal setting is another feature of health program design that can be used to help motivate 
individuals and keep them on course for changing their behavior. Goal setting has been shown to 
produce intrinsic motivation and increase performance beyond what is achieved by using solely 
monetary incentives (Corgnet et al., 2015). Cal Newport, professor and author of Deep Work, 
said that having a recording of all the things you still need to do can help you stay focused on the 
upcoming task (Newport, 2006). If not, that incomplete work could eat away at your 
concentration. This stems from something called the Zeigarnik Effect, which is the tendency to 
remember incomplete tasks instead of completed ones. Setting goals that are challenging but 
attainable is important to motivate without people giving up all-together if the goal is too far 
from their baseline ability. Setting goal gradients that are achievable and tied to rewards can be 
useful for motivating a behavior. 
Team Performance. 
 Goal setting can also be tied to team performance in a cooperation setting or a 
competitive setting to spark motivation. A recent study compared four different team incentive 
structures: 1) individual incentives, 2) social comparison (competitive) incentives, 3) social 
support team work incentives and 4) combined competitive and support team incentives, to 
determine which had the largest effect on increasing physical activity (Zhang et al., 2016). The 
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researchers found that the combined (competitive and support) incentive group and the 
competitive only group had a significantly higher effect in increasing exercise class attendance. 
This study showed that social comparison is most effective for increasing physical activity. 
Therefore, health programs should consider including competition and notify participants of their 
performance compared to others. 
 
Behavioral Science Framework and Methodology 
Standard economics tells us that providing people with information or economic 
incentives is enough to change behavior; however, behavioral economics tells us that people are 
not perfectly rational, and many decision heuristics and biases discussed previously play a role in 
decision-making. We can use these decision errors in order to design programs that steer people 
towards medication adherence. In order to systematically measure and test design features 
incorporating decision errors, it is important to develop a framework and methodology to 
measure the impact on behavior change. 
The first step is to identify the behavior of interest, such as medication adherence, and set 
goals for getting from one state to another. Reducing the rate of nonadherence from the current 
rate of 30% to 50% by even just a couple of percentage points can make a large impact. The next 
step is conducting a literature review around this behavior to understand how far away we are 
from our goal and what are the underlying behavioral drivers – why are patients not adhering to 
their medicine. The literature review is also crucial to understand what other studies that have 
already been conducted and how we can incorporate their research to inform design decision and 
expand beyond what has been tried in the past. Also, in this stage it is important to narrow in on 
specific decision heuristics or a design feature to narrow the scope (e.g. framing incentives in the 
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loss domain). After the literature review, conducting quantitative and/or qualitative data reviews 
will facilitate the evaluation of what factors are most important on influencing behavior change. 
This includes reviewing quantitative data to look for differences in demographics, 
socioeconomic status or other trends with nonadherence. The review of qualitative data through 
surveys or interviews will assess important factors on nonadherence and what could influence 
behavior change. Insights from this research can then be used to design an intervention 
experiment with a few different program design feature options or one design feature change to 
compare against the control. It is important to first pilot this change to conduct proper testing and 
analysis before scaling to ensure significant results. Additional measures could include a post-
experiment survey to assess the point of view of the participant and determine what components 
were most motivating for them. 
   
Challenges 
Motivation Crowding Out 
 Finding the sweet spot for health program incentives can be tricky. It is important to 
provide program incentives that are not so large that motivational crowding out of intrinsic 
motivation occurs. Large incentives have been shown to increase engagement during the 
intervention, but later crowd out intrinsic motivation which results in a large drop off after the 
intervention ends (Sen et al. 2014). Smaller incentives may work better but not too small, 
because small payments can also be worse than none at all (Gneezy & Rustichini, 2000). 
 Another concern is for participants at the lower end of the spectrum who may be 
demotivated and stop participating altogether if they are far from the top performers. Setting 
ceiling goals that are hard to reach or comparing people at different ends of the spectrum can be 
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very demotivating. Rewarding people for improvement in addition to top performance provides 
incentive for all individuals. Also, for group comparison or team performance features, grouping 
people that have a similar starting point may help prevent motivational crowding out from 
occurring. 
Long Term Behavior Change 
 Sustaining long term behavior change requires the elimination of existing habits and the 
formation of new habits. While financial incentives may work in the short-term, the goal is for 
habit formation to occur so that medication adherence continues to be high once the financial 
incentive is removed. In a weight loss experiment, Charness and Gneezy found that financial 
incentive-based interventions can facilitate habit formation post-intervention (Charness & 
Gneezy, 2009). While this is the hope for all interventions, sustained behavior change remains a 
significant challenge behavioral scientists are trying to tackle. It is also important to consider 
why incentives lead to sustained post-intervention behavior change in some contexts but not 
others. While some environments may enforce the desired behavior change, other environmental 
settings may work against the behavior. Modifying the environment when possible to reinforce 
the desired behavior can help sustain behavior change after the health program ends. 
 
Proof of Concept: Case Study 
HealthPrize 
 HealthPrize is a digital health company that partners with pharmaceutical companies to 
develop patient experience and adherence platforms to motivate patients to take their prescribed 
regimens. HealthPrize partnered with Boehringer Ingelheim to combat low patient adherence 
rates through the development of a digital platform. This platform, RespiPoints, provides chronic 
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obstructive pulmonary disease (COPD) and asthma patients with educational and motivational 
tools. It is well documented that patients with COPD often fail to adhere to medication regimens, 
which leads to increased hospitalization rates, increased mortality, and decreased quality of life 
(Boven et al., 2014). RespiPoints is a web and mobile platform that leverages insights from 
behavioral economics by using a gamified structure to engage and reward patients for 
participating in various activities. These activities are designed to increase adherence and 
motivate healthy behavior. Patients can accumulate points by reporting taking daily medicine, 
verifying monthly refills, reading educational information, or completing weekly quizzes and 
surveys. Accumulated points can then be redeemed via the in-app marketplace for gift cards. 
Patients are also able to track doctor appointment dates and share self-reporting data with their 
physician (HealthPrize Technologies, 2018). 
This partnership has already proven to be successful in a number of ways. First, in just 
nine months, the average number of prescription refills increased by 2.8 fills per patient with a 
verified prescription, a projected 3.9 fills over 12-months. Second, patients showed an 85% 
decrease in gap days, defined as the period of time between the expiration of the old prescription 
and the refill, from 10.9 to 1.6 gap days (Figure 5). Another success has been that the platform 
functions as a marketing engagement tactic that has increased patient reacquisition. Prior to 
signing up for RespiPoints, 16.2% of the total users on the platform were considered to have 
discontinued therapy, meaning that they had more than 60 gap days between refills. Therefore, 
the program was successful in reinitiating treatment in an inactive patient segment. Lastly, the 
program showed high participation, engagement, and satisfaction rates. Patients maintained a 
56% active participation rate over the course of the study, with an average of 50 minutes of 
interaction per month and 4.6 visits to the site weekly (Figure 5), and 71% of participants said 
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they would be “very likely” to recommend the platform to a friend or family member using the 
same treatment  (HealthPrize Technologies 2018). 
BI partnered with HealthPrize to use its digital platform technology to enhance revenue 
by improving adherence, capturing inactive patients, increasing health literacy, and providing 
brand differentiation (Boehringer Ingelheim 2018). After a successful pilot program, BI and 
HealthPrize opened the platform in April 2018 to any patient taking one of three BI medicines 
for asthma or COPD (Boehringer Ingelheim 2018). The success of this case study offers useful 
lessons to other health programs interested in improving user engagement and increasing 
medication adherence.  
 
Conclusion and Next Steps 
Medication nonadherence is a significant global problem and utilizing decision heuristics 
and biases that drive behavior in the design of program features can increase uptake and improve 
efficacy. HealthPrize and other digital health companies focused on medication adherence, can 
apply this framework for incorporating behavioral science in program design to further improve 
upon the success of their programs. These types of interventions can be described as libertarian 
paternalism because they help steer people towards healthier choices without limiting options or 
restricting freedom of choice. Using these techniques at scale is a low-cost strategy to promote 
healthy behavior change, which is in the best interest of patients, physicians and payers. 
With the shift to value-based care, government, employers and insurers are very interested in 
programs that increase healthy behaviors such as adhering to medication. Financial incentive 
programs based on healthy behavior have increasingly been used by employers and insurance 
companies to reduce health care costs. Although there has been much uptake and excitement 
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around these programs, thus far, we have not seen significant behavior change. Utilizing 
behavioral science to identify behavioral drivers and incorporate them into program design is 
essential to improve these programs. Incorporating the behavioral science concepts from this 
paper into the design of health programs to increase medication adherence is a cost-effective 
solution that will have a much larger impact on improving health and lowering healthcare costs.  
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Figure 1. United States Projected Health Expenditures 
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Figure 2. Investment Matrix to Determine Potential Digital Health Products 
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Figure 3. Digital Health Funding 2011-2018  
Source: Day & Zweig, 2018 
 
Figure 4. Corporate Investor Digital Health Transactions 2014-2019  
Source: Day & Zweig, 2019 
 




Figure 5.  Impact of RespiPoints Program on Patient Behavior  
Source: HealthPrize Technologies, 2018 
 
 
